November 4 @ 11:00 AM – 11:30 AM
Join Patrick Hanley, Ph.D., Chief and Director of the Cellular Therapy Program at Children’s National Hospital, as he dives into the CellBuilder Initiative and the exciting advancements in cell and gene therapy for the upcoming 2nd CHARM Symposium in this What’s the Buzz?! LIVE session with Chris Frew, CEO of BioBuzz Networks!
Dr. Hanley will discuss how the CellBuilder Initiative is transforming the future of cancer and rare disease treatments by bringing ready-to-use cell and gene therapies directly to hospitals.
Plus, don’t miss an exclusive look inside The CHARM Symposium and what’s on the horizon for cell and gene therapy.
Tune in to learn about the latest developments, partnerships, and the potential of this groundbreaking initiative to expand access to life-saving therapies.
About Patrick Hanley
Patrick Hanley, Ph.D. is the Chief and Director of the Cellular Therapy Program at the Children’s National Research Institute and an Associate Professor of Pediatrics. He leads efforts to develop, manufacture, and test novel cell and gene therapies for cancer and infection. With over 18 years of experience in immunology and cellular therapy, Dr. Hanley has overseen more than 25 clinical trials and the production of over 600 cellular therapy products. His work focuses on improving the potency of cellular therapies and reducing the time to bring them to patients. He is a leading expert in Good Manufacturing Practice (GMP) regulations and serves on the Board of Directors for the Foundation for the Accreditation of Cellular Therapy (FACT). Dr. Hanley is also a Commissioning Editor of the journal Cytotherapy and past Vice President of North America for the International Society for Cell and Gene Therapy (ISCT).